TwoFour Insight (@twofourinsight) 's Twitter Profile
TwoFour Insight

@twofourinsight

Regulatory and policy intelligence on US & India's life science market and industry. Clear Vision For The Life Sciences Industry - tweets ≠ endorsement

ID: 2317848834

linkhttp://twofourinsight.com calendar_today29-01-2014 21:54:12

11,11K Tweet

413 Followers

418 Following

TwoFour Insight (@twofourinsight) 's Twitter Profile Photo
TwoFour Insight
@twofourinsight

10 years ago

Accord Receives ANDA Approval for Generic Treanda - TwoFour Insight Group #India #pharma buff.ly/1s5JUHF

TwoFour Insight (@twofourinsight) 's Twitter Profile Photo
TwoFour Insight
@twofourinsight

10 years ago

Generic Crestor Market to Become Crowded in Near Future - TwoFour Insight Group #India #pharma buff.ly/1YTjeEn

TwoFour Insight (@twofourinsight) 's Twitter Profile Photo
TwoFour Insight
@twofourinsight

10 years ago

USFDA Puts Yunnan Hande Bio-Tech on Import Alert - TwoFour Insight Group #China #pharma buff.ly/20sFUvx

TwoFour Insight (@twofourinsight) 's Twitter Profile Photo
TwoFour Insight
@twofourinsight

10 years ago

India’s new patent policy spurs debate over implications for pharma statnews.com/pharmalot/2016… via STAT

TwoFour Insight (@twofourinsight) 's Twitter Profile Photo
TwoFour Insight
@twofourinsight

10 years ago

Drugs Technical Advisory Board (DTAB) Recommends Against Generic Substitution in #India - #pharma buff.ly/25kgsPN

TwoFour Insight (@twofourinsight) 's Twitter Profile Photo
TwoFour Insight
@twofourinsight

10 years ago

Drugs Technical Advisory Board (DTAB) Recommends Against Generic Substitution in #India - #pharma buff.ly/1Ro0Qxz

TwoFour Insight (@twofourinsight) 's Twitter Profile Photo
TwoFour Insight
@twofourinsight

10 years ago

Drugs Technical Advisory Board (DTAB) Recommends Against Generic Substitution in #India - #pharma buff.ly/1TvAxwM

TwoFour Insight (@twofourinsight) 's Twitter Profile Photo
TwoFour Insight
@twofourinsight

10 years ago

Indoco Receives USFDA Nod for Its Goa Plant II - TwoFour Insight Group #India #pharma buff.ly/1OWY201

TwoFour Insight (@twofourinsight) 's Twitter Profile Photo
TwoFour Insight
@twofourinsight

10 years ago

USFDA Approves Jubilant HollisterStier's First ANDA for an Injectable - #India #pharma TwoFour Insight Group buff.ly/1UdD7Vb

TwoFour Insight (@twofourinsight) 's Twitter Profile Photo
TwoFour Insight
@twofourinsight

10 years ago

Newron #Pharma of #Italy Withdraws Indian Patent Application for Antimigraine Drug - TwoFour Insight Group #India buff.ly/1TzWL0P

TwoFour Insight (@twofourinsight) 's Twitter Profile Photo
TwoFour Insight
@twofourinsight

10 years ago

Indoco Receives USFDA Nod for Its Goa Plant II - TwoFour Insight Group #India #pharma buff.ly/25lXKHB

TwoFour Insight (@twofourinsight) 's Twitter Profile Photo
TwoFour Insight
@twofourinsight

10 years ago

USFDA Approves Jubilant HollisterStier's First ANDA for an Injectable - #India #pharma TwoFour Insight Group buff.ly/1RqLMiH

TwoFour Insight (@twofourinsight) 's Twitter Profile Photo
TwoFour Insight
@twofourinsight

10 years ago

Newron #Pharma of #Italy Withdraws Indian Patent Application for Antimigraine Drug - TwoFour Insight Group #India buff.ly/25mwAjG

TwoFour Insight (@twofourinsight) 's Twitter Profile Photo
TwoFour Insight
@twofourinsight

10 years ago

USFDA Approves Jubilant HollisterStier's First ANDA for an Injectable - #India #pharma TwoFour Insight Group buff.ly/1UdDi2M

TwoFour Insight (@twofourinsight) 's Twitter Profile Photo
TwoFour Insight
@twofourinsight

10 years ago

Newron #Pharma of #Italy Withdraws Indian Patent Application for Antimigraine Drug - TwoFour Insight Group #India buff.ly/1RrmeC7

TwoFour Insight (@twofourinsight) 's Twitter Profile Photo
TwoFour Insight
@twofourinsight

10 years ago

Indoco Receives USFDA Nod for Its Goa Plant II - TwoFour Insight Group #India #pharma buff.ly/1TyVkQ7

TwoFour Insight (@twofourinsight) 's Twitter Profile Photo
TwoFour Insight
@twofourinsight

10 years ago

Sanofi Obtains Indian Patent for Azabicycloalkane Derivatives - TwoFour Insight Group twofourinsight.com/sanofi-obtains…

TwoFour Insight (@twofourinsight) 's Twitter Profile Photo
TwoFour Insight
@twofourinsight

10 years ago

Cost of #Pharma Business Set to Increase in #India - User Fees Rising Six-Fold | TwoFour Insight Group buff.ly/1TK8qan

TwoFour Insight (@twofourinsight) 's Twitter Profile Photo
TwoFour Insight
@twofourinsight

10 years ago

Cost of #Pharma Business Set to Increase in #India - User Fees Rising Six-Fold | TwoFour Insight Group buff.ly/1NSObIo

TwoFour Insight (@twofourinsight) 's Twitter Profile Photo
TwoFour Insight
@twofourinsight

10 years ago

Cost of #Pharma Business Set to Increase in #India - User Fees Rising Six-Fold | TwoFour Insight Group buff.ly/1VmdEeC